Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), the leading RNA interference (RNAi) therapeutics company, and Sharp, part of UDG Healthcare, today announced an agreement for the packaging of Alnylam’s approved RNAi therapeutic in European markets. In accordance with this agreem … Read More »

Last June, 10 major pharmaceutical companies — Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Institut De Recherches Servier, Janssen, Merck, and Novartis — inked an agreement to build a shared platform called MELLODDY (Machine Learning Ledger Orchestration … Read More »

PHILADELPHIA, PA (September 16, 2020) — Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with malignant glioblastomas (GBM) and other solid tumors with significant unmet medical needs, today announced the appointment of Wendy DiCicc … Read More »

As Pfizer moves ahead in COVID-19 vaccine research at record speeds, executives on Tuesday detailed a “mostly mild to moderate” safety profile, with rare instances of severe or grade 4 side effects. In phase 3 data through Aug. 27, trial participants who’d received only the … Read More »

Brattleboro, VT (September 15, 2020) – Omega Optical (Omega or the Company), a leading manufacturer of precision optical filters and coatings, announced today that it has been acquired by Artemis Capital Partners (Artemis), a Boston-based private equity firm focused exclusiv … Read More »

MyBloodHealth® develops an end-to-end care plan for the perioperative patient, designed to help manage anemia in a simple, efficient, cost-effective way. Accumen Inc. is helping healthcare get better, faster. Today the company launched its first software-as-a-service (SaaS) … Read More »

A federal appeals court on Monday cleared the way for New York state to collect about $200 million from drug manufacturers and distributors by imposing a surcharge on them to defray the costs of combating the opioid addiction epidemic. The 2nd U.S. Circuit Court of Appeals r … Read More »

For Immediate Release CATO SMS ACQUIRES ARRAY BIOSTATISTICS Global Provider Expands Specialized Clinical Research Offering with Enhanced Biostatistical Services CARY, N.C., September 15, 2020 – CATO SMS announced today that it has acquired Wilmington, NC-based Array Biostati … Read More »

AUSTIN, Texas, September 15, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track designation for its lead investigational drug, Rhenium NanoLiposo … Read More »

It’s been a big week for the field of antibody-drug conjugates. In the largest deal in its 33-year history, Gilead Sciences has agreed to pay $21 billion to acquire Immunomedics and its recently-approved antibody-drug conjugate (ADC), Trodelvy. Separately, Merck & Co. sa … Read More »

Elsevier, a global research publishing and information analytics provider, is collaborating with Pending.AI (PAI), a start-up focused on developing artificial intelligence (AI) solutions for drug discovery, to develop the predictive retrosynthesis tool based on deep learning … Read More »

CHICAGO, Sept. 14, 2020 – AbelsonTaylor, one of the world’s premier health and wellness advertising agencies, has promoted Erica Rivera from senior director to vice president of engagement strategy. She will oversee multichannel marketing strategy for all agency clients, sup … Read More »

Following an epic drum battle that went viral, Dave Grohl has written a theme song for his young superstar opponent, 10-year-old drummer Nandi Bushell. Bushell, who has appeared on Ellen and regularly uploads videos to her 100,000-subscriber YouTube channel, first challenged … Read More »

adMare Academy Announces New Executive Institute Cohort After receiving a record number of applications from across Canada, adMare BioInnovations (adMare) is pleased to announce the successful applicants for its 2020-2021 Executive Institute cohort. Launched in 2018 with the … Read More »

Merck is making a major investment into Bothwell, Washington-based Seattle Genetics with two strategic oncology deals. Seattle Genetics’ shares rocketed 12% in premarket trading at the news. In the first deal, the two companies will work to develop Seattle Genetics’ ladiratu … Read More »

Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so. On 6 September, the standard review process triggered a voluntary pause to va … Read More »

SciBite, the award-winning semantic technology company, today announced the launch of SciBiteAI, a state-of-the-art Artificial Intelligence software platform for leveraging machine learning models alongside semantic technologies to unlock insights into Life Sciences data. Sc … Read More »

– Unblinded Subgroup Analyses Show Consistent Effect for MRI Lesion Suppression Across Different Populations – – Time Course of MRI Lesion Suppression Shows Reduction of Lesions Already Present at First Post-Baseline Scan at Week 6, Validating Rapid Attainment of Stable Ther … Read More »

SAN DIEGO & PHILADELPHIA–(BUSINESS WIRE)–ProSciento, Inc., a leading specialty clinical research organization (CRO) focused on non-alcoholic steatohepatitis (NASH), diabetes, obesity, and related metabolic diseases, announced today the closing of a growth financing fro … Read More »

Global contract packaging organisation (CPO), Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials. The new fully automated packaging line for vials will start operations in Q1 2021 and will increase … Read More »